{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-019384","form_type":"8-K","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2026-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.283315+00:00","generated_at":"2026-05-16T01:07:57.718148+00:00","sec_items":["3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Silo Pharma authorizes $1M buyback; pays IR consultant 848k shares","bullets":["Board approved stock repurchase program up to $1 million of common stock.","Shares outstanding: 13,318,273 as of Sept 30, 2025.","Issued 848,320 shares to IR consultant as $250k commitment fee at $0.2947/share.","No proceeds received; shares issued under Section 4(a)(2) exemption.","Buyback discretionary; may be suspended or discontinued anytime."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-019384","json":"https://secwatch.observer/filing/0001213900-26-019384.json","markdown":"https://secwatch.observer/filing/0001213900-26-019384.md","text":"https://secwatch.observer/filing/0001213900-26-019384.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390026019384/0001213900-26-019384-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390026019384/ea0278025-8k_silo.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:07:57.718148+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}